ETFs
A
AVBP
Arrivent Biopharma Inc
18.32
+0.38+2.09%Opening13:01 10/20 EDT
OPEN/PREV CLOSE17.94/17.94
TODAY RANGE17.57-18.59
VOL261.41K
MARKET CAP903.07M
52 WEEK RANGE11.36-35.83
AVG VOL (3M)1.01M
% TURNOVER0.52%
TURNOVER--
P/E (TTM)-4.9886
% RANGE5.69%
EPS(TTM)-3.6714
P/E(FORWARD)-4.4122
P/B2.412
BVPS7.59
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP821.23M
SHARES OUTSTANDING49.31M
NEXT EARNINGS11/09-11/13
FREE FLOAT44.84M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
ArriVent highlights firmonertinib Phase 1b lung cancer data
TipRanks·10/13 10:32
ArriVent BioPharma Begins U.S. Trial of ARR-002
TipRanks·10/12 20:10
ArriVent Biopharma doses first patient in ARR-002 trial
Benzinga·10/08 12:58
Eli Lilly To Rally Over 21%? Here Are 10 Top Analyst Forecasts For Thursday
Dow Jones·10/08 10:42
ArriVent BioPharma Is Maintained at Buy by HC Wainwright & Co.
TipRanks·10/08 10:21
ArriVent Biopharma price target lowered to $27 from $47 at H.C. Wainwright
Dow Jones·10/07 19:21
ArriVent BioPharma Is Maintained at Buy by Citigroup
Dow Jones·10/07 19:21
ArriVent BioPharma Price Target Cut to $20.00/Share From $40.00 by Citigroup
Benzinga·10/07 19:11
Citigroup Maintains Buy on ArriVent BioPharma, Lowers Price Target to $20
Dow Jones·10/07 18:58
ArriVent BioPharma Price Target Cut to $22.00/Share From $45.00 by Jones Trading
Same Industry
Name/Symbol
Change%
Price